Impact of Bionanointeractions of Engineered Nanoparticles for Nanomedicine

[1]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[2]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[3]  Joseph M. DeSimone,et al.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.

[4]  Ashutosh Chilkoti,et al.  Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumors after a single injection , 2009, Nature materials.

[5]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[7]  Gaurav Sahay,et al.  Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[8]  G. Vecchio,et al.  In Vivo toxicity assessment of gold nanoparticles in Drosophila melanogaster , 2011 .

[9]  Mauro Ferrari,et al.  Nanomedicine in cancer therapy: Innovative trends and prospects , 2011, Cancer science.

[10]  Yu Matsumoto,et al.  Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting , 2011, Science Translational Medicine.

[11]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[12]  Claudia Calcagno,et al.  Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. , 2008, Nano letters.

[13]  Patrick Couvreur,et al.  Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[14]  Nicholas A Peppas,et al.  A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  T. Allen.  Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.

[16]  Hicham A. Chibli,et al.  InP/ZnS as a safer alternative to CdSe/ZnS core/shell quantum dots: in vitro and in vivo toxicity assessment. , 2013, Nanoscale.

[17]  M. Byrne,et al.  Injectable nanomaterials for drug delivery: carriers, targeting moieties, and therapeutics. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  A. Chilkoti,et al.  In situ growth of a PEG-like polymer from the C terminus of an intein fusion protein improves pharmacokinetics and tumor accumulation , 2010, Proceedings of the National Academy of Sciences.

[19]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[20]  Samir Mitragotri,et al.  Physical approaches to biomaterial design. , 2009, Nature materials.

[21]  Ilker S. Bayer,et al.  Water-repellent cellulose fiber networks with multifunctional properties. , 2011, ACS applied materials & interfaces.

[22]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[23]  Chad A Mirkin,et al.  Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. , 2011, Nano letters.

[24]  G Vecchio,et al.  In vivo assessment of CdSe-ZnS quantum dots: coating dependent bioaccumulation and genotoxicity. , 2012, Nanoscale.

[25]  R. Weissleder,et al.  Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.

[26]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[27]  Stephanie E. A. Gratton,et al.  Imparting size, shape, and composition control of materials for nanomedicine. , 2006, Chemical Society reviews.

[28]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[29]  J. Pérez‐Juste,et al.  Crystal structure dependence of the elastic constants of gold nanorods , 2006 .

[30]  L. Samson,et al.  Balancing repair and tolerance of DNA damage caused by alkylating agents , 2012, Nature Reviews Cancer.

[31]  G. Vecchio,et al.  Toxicity of citrate-capped AuNPs: an in vitro and in vivo assessment , 2011 .

[32]  Ashutosh Chilkoti,et al.  Nanomaterials for Drug Delivery , 2012, Science.

[33]  Mark B. Carter,et al.  The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers , 2011, Nature materials.

[34]  Jonathan F. Lovell,et al.  Lipoprotein-Inspired Nanoparticles for Cancer Theranostics , 2011, Accounts of chemical research.

[35]  G. Vecchio,et al.  Molecular response of Escherichia coli adhering onto nanoscale topography , 2012, Nanoscale Research Letters.

[36]  Zahi A Fayad,et al.  The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis. , 2011, Biomaterials.

[37]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[38]  A. Athanassiou,et al.  Microscale patterning of hydrophobic/hydrophilic surfaces by spatially controlled galvanic displacement reactions. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[39]  G Vecchio,et al.  Physical assessment of toxicology at nanoscale: nano dose-metrics and toxicity factor. , 2011, Nanoscale.

[40]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[41]  Yong Ding,et al.  Surface analysis using shell-isolated nanoparticle-enhanced Raman spectroscopy , 2012, Nature Protocols.

[42]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[43]  G. Vecchio,et al.  Impact of nanoscale topography on genomics and proteomics of adherent bacteria. , 2011, ACS nano.

[44]  Michael J Sailor,et al.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.

[45]  G. Vecchio,et al.  Mutagenic effects of gold nanoparticles induce aberrant phenotypes in Drosophila melanogaster. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[46]  Roberto Cingolani,et al.  Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.

[47]  Istvan Toth,et al.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.

[48]  A. Athanassiou,et al.  Modulating antibacterial properties using nanotechnology. , 2011, Nanomedicine.

[49]  Roberto Cingolani,et al.  Monodispersed and size-controlled multibranched gold nanoparticles with nanoscale tuning of surface morphology. , 2011, Nanoscale.

[50]  Ting Xu,et al.  Toward functional nanocomposites: taking the best of nanoparticles, polymers, and small molecules. , 2013, Chemical Society reviews.

[51]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[52]  R Cingolani,et al.  Neurons sense nanoscale roughness with nanometer sensitivity , 2010, Proceedings of the National Academy of Sciences.

[53]  Linlin Li,et al.  Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.

[54]  Roberto Cingolani,et al.  SiO2 nanoparticles biocompatibility and their potential for gene delivery and silencing. , 2012, Nanoscale.

[55]  B. Lorber,et al.  A synthetic nanomaterial for virus recognition produced by surface imprinting , 2013, Nature Communications.

[56]  Samir Mitragotri,et al.  Red blood cell-mimicking synthetic biomaterial particles , 2009, Proceedings of the National Academy of Sciences.

[57]  G. Böhm,et al.  Protein and peptide delivery via engineered polyomavirus‐like particles , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  M. Kovalenko,et al.  Prospects of colloidal nanocrystals for electronic and optoelectronic applications. , 2010, Chemical reviews.

[59]  Neetu Singh,et al.  Nanoparticles that communicate in vivo to amplify tumour targeting. , 2011, Nature materials.

[60]  Heng Zhang,et al.  Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux. , 2012, ACS nano.

[61]  Roberto Cingolani,et al.  Concentration-Dependent, Size-Independent Toxicity of Citrate Capped AuNPs in Drosophila melanogaster , 2012, PloS one.

[62]  Hong Ding,et al.  Image Guided Biodistribution and Pharmacokinetic Studies of Theranostics , 2012, Theranostics.

[63]  Roberto Cingolani,et al.  Nanotechnology tools for antibacterial materials. , 2013, Nanomedicine.

[64]  Adam P. Silverman,et al.  High-throughput synthesis and screening of platinum drug candidates , 2000, JBIC Journal of Biological Inorganic Chemistry.

[65]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[66]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[67]  Zahi A. Fayad,et al.  Perspectives and opportunities for nanomedicine in the management of atherosclerosis , 2011, Nature Reviews Drug Discovery.

[68]  W. Parak.  Complex Colloidal Assembly , 2011, Science.

[69]  Roberto Cingolani,et al.  Framing the nano-biointeractions by proteomics , 2012, BiOS.

[70]  Volker Wagner,et al.  The emerging nanomedicine landscape , 2006, Nature Biotechnology.